The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)

Clinical trial NCT01354093 · COMPLETED

Trial details

NCT number: NCT01354093
Sponsor: Paul S. Bernstein
Status: COMPLETED
Study type: OBSERVATIONAL

Idiopathic Juxtafoveal Telangiectasia

Start date: 2011-11-01
Primary completion: 2017-01-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.